Global A Disintegrin And Metalloproteinase With Thrombospondin Motifs 5 Pipeline Review 2016 - Research and Markets

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "A Disintegrin And Metalloproteinase With Thrombospondin Motifs 5 (A Disintegrin And Metalloproteinase With Thrombospondin Motifs 11 or Aggrecanase 2 or ADMP2 or ADAMTS5 or EC 3.4.24.) - Pipeline Review, H2 2016" report to their offering.

A disintegrin and metalloproteinase with thrombospondin motifs 5 or ADAMTS5 is an enzyme encoded by the ADAMTS5 gene. It plays an important role in the destruction of aggrecan in arthritic diseases and in proteolytic processing mostly during the peri-implantation period.

A Disintegrin And Metalloproteinase With Thrombospondin Motifs 5 pipeline Target constitutes close to 5 molecules. Out of which approximately 5 molecules are developed by Companies.The molecules developed by Companies in Phase II, Phase I, Preclinical and Discovery stages are 1, 1, 1 and 2 respectively.

Our latest report A Disintegrin And Metalloproteinase With Thrombospondin Motifs 5 - Pipeline Review, H2 2016, outlays comprehensive information on the A Disintegrin And Metalloproteinase With Thrombospondin Motifs 5 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews key players involved in A Disintegrin And Metalloproteinase With Thrombospondin Motifs 5 targeted therapeutics development, features dormant and discontinued projects and latest news and press releases.

Key Topics Covered:

1. Introduction
2. A Disintegrin And Metalloproteinase With Thrombospondin Motifs 5 Overview
3. Therapeutics Development
4. Pipeline Products for A Disintegrin And Metalloproteinase With Thrombospondin Motifs 5 - Overview
5. Pipeline Products for A Disintegrin And Metalloproteinase With Thrombospondin Motifs 5 - Comparative Analysis
6. A Disintegrin And Metalloproteinase With Thrombospondin Motifs 5 - Therapeutics under Development by Companies
7. A Disintegrin And Metalloproteinase With Thrombospondin Motifs 5 - Therapeutics under Investigation by Universities/Institutes
8. A Disintegrin And Metalloproteinase With Thrombospondin Motifs 5 Products Glance
9. Late Stage Products
10. Clinical Stage Products
11. Early Stage Products
12. A Disintegrin And Metalloproteinase With Thrombospondin Motifs 5 - Products under Development by Companies
13. A Disintegrin And Metalloproteinase With Thrombospondin Motifs 5 - Products under Investigation by Universities/Institutes
14. A Disintegrin And Metalloproteinase With Thrombospondin Motifs 5 - Companies Involved in Therapeutics Development

• Asahi Kasei Pharma Corp.
• GlaxoSmithKline Plc
• Oscotec Inc.
• Paradigm Biopharmaceuticals Limited
  

For more information about this report visit http://www.researchandmarkets.com/research/mrrsc8/a_disintegrin_and